Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Plans Research Zones For Cutting-Edge Medicine R&D

This article was originally published in PharmAsia News

Executive Summary

Japan's government plans to establish research zones around the nation to bring top scientists together on medical research and development efforts. The main focus of the effort, scheduled for completion later this year, is work on stem cells and other cutting-edge medicines. Subsidies and more-relaxed regulations are to be available within each zone that combines university and private industry in advanced medical research. Priority is to be given to biotech pharmaceuticals, induced pluripotent stem cells and regenerative medicine. (Click here for more - a subscription may be required

You may also be interested in...



Dr Reddy's Isolates Data Service Centers Among Preventive Actions Responding To Cyberattack

J&J Faces Fraud Claims From Merger With Surgical Robot Firm

Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.

As Pandemic Boosts Demand For Immunity Supplements, Dentovations Launches Self+ Line

based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel